Predictive Programming? FDA Says Monkeypox Can “Mutate” If Anti-Viral Drugs Are Overused

by | Sep 17, 2022 | Headline News

Do you LOVE America?


    The monkeypox could “mutate” if antiviral drugs are overused, according to a recent warning from the Food and Drug Administration.  The virus is only one mutation away from evading a key antiviral drug being used to treat at-risk patients if the FDA is to be believed.

    Is this predictive programming? Are we to expect a surge and worse outbreak of monkeypox in the coming weeks?

    The FDA has issued new guidance for the antiviral drug known as tecovirimat, or Tpoxx, and it was published this week online and in updated labeling.

    The regulator says lab and animal studies, and evidence from a human case of this family of viruses, suggest monkeypox has “several genetic pathways” to evolve resistance to tecovirimat. Many “require only a single amino acid change,” the FDA said.

    “Most patients with intact immune systems really need supportive care and pain control, but often do not need to be stepped up to antiviral treatment,” the Centers for Disease Control and Prevention’s Dr. Sapna Bamrah Morris said over the weekend, in a webinar hosted by the Infectious Diseases Society of America.

    Is this a warning of what’s to come? Are the rulers preparing us to accept another lockdown over a mutated monkeypox virus? Anything is possible in these times we live in. If it consolidates power into the hands of the government, we can expect the situation to be pushed hard. Never let a good crisis go to waste, right?

    The CDC has been closely tracking mutations in the virus to watch for potential variants that could be resistant to the monkeypox treatment. A portion of positive tests around the country is being forwarded to the agency for genetic sequencing, according to a report by CBS News.

    No cases have been spotted so far of a strain that can evade tecovirimat, though the ruling class is warning of a “low barrier to resistance” which poses a risk that a resistant variant could emerge and spread.

    Tecovirimat is still available for doctors to obtain for their patients through an “expanded access” protocol set up by the CDC. White House officials have touted their efforts to cut down on the paperwork in order to get the drug through this so-called “compassionate use” channel. Or, are they actively trying to make sure they have a scapegoat for a drug-resistant form of the monkeypox?

    Even as cases slow, and worldwide cases (global population approaching 8 billion) have yet to top 23,000, the panic and fear-mongering continues. Is monkeypox going to be the “cause” of another lockdown? It seems like there are gearing up for several different angles. If one doesn’t work out, perhaps they’ll try another, as the public has already been sensitized to the possibility.


    It Took 22 Years to Get to This Point

    Gold has been the right asset with which to save your funds in this millennium that began 23 years ago.

    Free Exclusive Report
    The inevitable Breakout – The two w’s

      Related Articles


      Join the conversation!

      It’s 100% free and your personal information will never be sold or shared online.


      Commenting Policy:

      Some comments on this web site are automatically moderated through our Spam protection systems. Please be patient if your comment isn’t immediately available. We’re not trying to censor you, the system just wants to make sure you’re not a robot posting random spam.

      This website thrives because of its community. While we support lively debates and understand that people get excited, frustrated or angry at times, we ask that the conversation remain civil. Racism, to include any religious affiliation, will not be tolerated on this site, including the disparagement of people in the comments section.